Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Mylan’s Biosimilars Close In On $1bn Milestone
Firm Reveals Annual Sales Total From Biosimilars Business
Mylan’s cumulative sales of biosimilars are approaching $1bn in total • Source: Shutterstock
More from Biosimilars
More from Products